ScoreWhy is Biocon Ltd. ?
1
Negative results in Sep 25
- PAT(Latest six months) At Rs 125.13 cr has Grown at -79.57%
- PBT LESS OI(Q) At Rs 90.20 cr has Fallen at -38.8% (vs previous 4Q average)
- INTEREST(Latest six months) At Rs 548.90 cr has Grown at 25.95%
2
With ROCE of 4.4, it has a Attractive valuation with a 1.8 Enterprise value to Capital Employed
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 2.11%, its profits have fallen by -66.6%
3
High Institutional Holdings at 28.71%
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Biocon for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
Biocon
2.69%
0.06
32.66%
Sensex
-4.3%
0.44
11.83%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
19.66%
EBIT Growth (5y)
13.99%
EBIT to Interest (avg)
4.40
Debt to EBITDA (avg)
4.53
Net Debt to Equity (avg)
0.39
Sales to Capital Employed (avg)
0.46
Tax Ratio
8.38%
Dividend Payout Ratio
5.92%
Pledged Shares
0
Institutional Holding
31.30%
ROCE (avg)
6.69%
ROE (avg)
5.62%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
64
Industry P/E
31
Price to Book Value
2.12
EV to EBIT
41.64
EV to EBITDA
19.25
EV to Capital Employed
1.81
EV to Sales
4.00
PEG Ratio
NA
Dividend Yield
0.12%
ROCE (Latest)
4.36%
ROE (Latest)
1.74%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend12What is working for the Company
CASH AND CASH EQUIVALENTS(HY)
Highest at Rs 4,601.10 cr
DEBT-EQUITY RATIO(HY)
Lowest at 0.62 times
PAT(Q)
Highest at Rs 437.20 cr.
-6What is not working for the Company
PBT LESS OI(Q)
At Rs 108.30 cr has Fallen at -32.3% (vs previous 4Q average
ROCE(HY)
Lowest at 4.31%
NON-OPERATING INCOME(Q)
is 51.99 % of Profit Before Tax (PBT
Loading Valuation Snapshot...
Here's what is working for Biocon
Profit After Tax (PAT) - Quarterly
At Rs 437.20 cr has Grown at 275.2% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 116.51 CrMOJO Watch
Near term PAT trend is very positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
Highest at Rs 437.20 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Cash and Cash Equivalents - Half Yearly
Highest at Rs 4,601.10 cr
in the last six half yearly periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debt-Equity Ratio - Half Yearly
Lowest at 0.62 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Biocon
Profit Before Tax less Other Income (PBT) - Quarterly
At Rs 108.30 cr has Fallen at -32.3% (vs previous 4Q average)
over average PBT of the previous four quarters of Rs 159.98 CrMOJO Watch
Near term PBT trend is very negative
PBT less Other Income (Rs Cr)
Non Operating Income - Quarterly
is 51.99 % of Profit Before Tax (PBT)
MOJO Watch
The company's income from non business activities is high; which is not a sustainable business model
Non Operating Income to PBT
Non Operating Income - Quarterly
Highest at Rs 117.30 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
